Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Antiviral Research|March 4, 2008
C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infectionJustin G Julander, Ramona Skirpstunas, Venkatraman Siddharthan, et al.American Journal of Clinical Pathology|June 21, 2007
A 22-plex chemiluminescent microarray for pneumococcal antibodiesJerry W Pickering, Justin D Hoopes, Matthew C Groll, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
TLR3 deletion limits mortality and disease severity due to Phlebovirus infectionBrian B Gowen, Justin D Hoopes, Min-Hui Wong, et al.Biotechniques|March 30, 2007
Validating a custom multiplex ELISA against individual commercial immunoassays using clinical samplesMichael Liew, Matthew C Groll, James E Thompson, et al.International Journal of Antimicrobial Agents|January 22, 2008
Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes and effects of cidofovir treatmentDonald F Smee, Brian B Gowen, Miles K Wandersee, et al.Plos One|January 6, 2012
Triple combination antiviral drug (TCAD) composed of amantadine, oseltamivir, and ribavirin impedes the selection of drug-resistant influenza A virusJustin D Hoopes, Elizabeth M Driebe, Erin Kelley, et al.Antimicrobial Agents and Chemotherapy|July 22, 2009
Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitroJack T Nguyen, Justin D Hoopes, Donald F Smee, et al.Plos One|February 25, 2010
Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitroJack T Nguyen, Justin D Hoopes, Minh H Le, et al.Antiviral Chemistry & Chemotherapy|March 17, 2010
Induction of interferon-gamma-inducible protein 10 by SARS-CoV infection, interferon alfacon 1 and interferon inducer in human bronchial epithelial Calu-3 cells and BALB/c miceYohichi Kumaki, Craig W Day, Kevin W Bailey, et al.Pageof 1